Prevymis (letermovir) - Merck (MSD)
LONGITUDINAL TCR SEQUENCING REVEALS DONOR-DEPENDENT IMMUNE RECONSTITUTION PATTERNS AFTER PEDIATRIC ALLOGENEIC HSCT FOR PRIMARY IMMUNODEFICIENCIES (EHA 2026) - May 12, 2026 - Abstract #EHA-5090; PF1141; Pres time: Jun 12, 2026; 06:45 PM - 07:45 PM; Location: Hall A; "In contrast, letermovir administration did not significantly affect global TCR diversity at any time point...Newly generated donor-derived clones dominate long-term recovery, while virus-associated expansions reflect adaptive immune remodeling. TCR sequencing may support immune monitoring after pediatric transplantation." 
Clinical • Acute Graft versus Host Disease • Bone Marrow Transplantation • Chronic Graft versus Host Disease • Genetic Disorders • Graft versus Host Disease • Immunology • Pediatrics • Primary Immunodeficiency
https://s3.eu-central-1.amazonaws.com/m-anage.com.storage.eha/temp/eha26_abstract/PF1141.pdf
 
Guanghua Zhu 1; Wei Yang 1; Jie Zheng 1; Bin Wang 1; Yanhui Luo 1; Jun Yang 1; Chenguang Jia 1; Yuanfang Jing 1; Wei Chen 1; Shunjin Zhang 2; Xiaoxia Wang 2; Jinghua Wu 2; Xiao Liu 3; Maoquan Qin1
 
May 12, 2026
 
Prev Next